Department of Molecular Cell Biology

Latest PUBLICATIONS

Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation
Rondeau V., Bansal S., Buttigieg M. M., Zeng A. G., Chan D. Y., Chan-Seng-Yue M., Jin L., McLeod J., Kates M., Donato E., Stelmach P., Vlasschaert C., Yang Y., Gupta A., Genta S., Sanz-Garcia E., Shlush L., Ribeiro M., Butler M. O., Abelson S., Minden M. D., Saibil S. D., Chan S. M., Rauh M. J., Trumpp A., Dick J. E. & Vanner R. J. (2026), Cancer Research. 86, 4, p. 845-857

Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial
Meylan M., Tian Y., Wu L., Ling A. L., Kovarsky D., Barlow G. L., Nguyen L. D., Pyrdol J., Marx S., Westphal L., Michel J., Gonzalez Castro L. N., Dumont S., Santos A., Tirosh I., Suvà M. L., Chiocca E. A. & Wucherpfennig K. W. (2026), Cell
Submitted Version

Aged B cells as a candidate cell of origin for diffuse large B cell lymphoma: A multi-modal analysis of somatic mutation, clonality, and transcriptional programs
Dadi G., Varon B., Naffaa M., Feldman T., Horowitz N., Kaushansky N. & Shlush L. (2025), Blood. 146, Supplement 1, p. 461-462

Evaluating cell state-targeting CAR-T cells in glioblastoma
Kovatsis S., Mount C., Boxer E., Zhong J., Dumont S., Gerovasilis D., Lu J., Tirosh I. & Suva M. (2025), Neuro-Oncology. 27, Supplement_5, p. v347

Deciphering the spatial architecture of transcriptional heterogeneity in glioblastoma at single cell resolution
Mount C., Wen Z., Greenwald A., Kovatsis S., Lu J., Gerovasilis D., Tirosh I. & Suva M. (2025), Neuro-Oncology. 27, Supplement_5, p. v461
All publications